Clareo Health | Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bone Therapeutics S.A
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects of 18 years of age or older
Subjects must belong to one of this group: Rheumatoid Arthritis (RA) Subjects OR Psoriatic Arthritis (PsA) Subjects OR Spondylarthritis (SpA) Subjects
You may not be if
Subjects diagnosed with other autoimmune/inflammatory diseases other than Crohn's disease, psoriasis, uveitis, Sjögren's syndrome and auto-immune thyroiditis
Subjects with an active cancer and currently receiving a cancer treatment
Women with known pregnancy
Breastfeeding women
Subjects with a known history of HIV and/or Hepatitis B and/or Hepatitis C infection and/or positive for HBs antigens
